Species distribution and antifungal susceptibilities of yeast clinical isolates from Three Hospitals in Korea, 2001 to 2007

Korean Journal of Laboratory Medicine

Volumn 30, Issue 4, 2010, Pages 364-372

  Lee, Mi Kyung ^a   Yong, Dongeun ^b   Kim, Myungsook ^b   Kim, Mi Na ^c   Lee, Kyungwon ^b  

^a Chung Ang University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Fluconazole; Surveillance; Voriconazole; Yeast

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA; CRYPTOCOCCUS NEOFORMANS; DISK DIFFUSION; DRUG EFFECT; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; RHODOTORULA; SOUTH KOREA; TRICHOSPORON; YEAST;

ANTIFUNGAL AGENTS; CANDIDA; CRYPTOCOCCUS NEOFORMANS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HOSPITALS; HUMANS; PYRIMIDINES; REPUBLIC OF KOREA; RHODOTORULA; TRIAZOLES; TRICHOSPORON; YEASTS;

EID: 79952063543     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2010.30.4.364     Document Type: Article

References (19)

1. Chae MJ, Shin JH, Cho D, Kee SJ, Kim SH, Shin MG, et al. Antifungal susceptibilities and distribution of Candida species recovered from blood cultures over an 8-yr period. Korean J Lab Med 2003; 23:329-35.
2. Shin JH, Kim HR, Lee JN. Distribution and antifungal susceptibility of Candida species isolated from clinical specimens during the past six years. Korean J Clin Microbiol 2004;7:164-70.
3. Lee MK, Kim HR, Kang JO, Kim MN, Kim EC, Kim JS, et al. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study. Mycoses 2007;50:148-9.
4. Lee JS, Shin JH, Lee K, Kim MN, Shin BM, Uh Y, et al. Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea. Yonsei Med J 2007;48:779-86. (Pubitemid 350130467)
5. Kim SH, Shin JH, Kim EC, Lee K, Kim MN, Lee WG, et al. The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study. Med Mycol 2009;47:296-304.
6. Yoo JI, Choi CW, Lee KM, Kim YK, Kim TU, Kim EC, et al. National surveillance of antifungal susceptibility of Candida species in South Korean hospitals. Med Mycol 2009;47:554-8.
7. Pfaller MA, Diekema DJ, Rinaldi MG, Barnes R, Hu B, Veselov AV, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-yr analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005;43:5848-59. (Pubitemid 43100628)
8. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-yr analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007;45:1735-45. (Pubitemid 46933900)
9. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Bijie H, Dzierzanowska D, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-yr analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2009;47:117-23.
10. Isenberg HD. Clinical microbiology procedures handbook. 2nd ed. Washington, DC: ASM Press, 2003:3.11.2.
11. Sheehan DJ; National Committee for Clinical Laboratory Standards. Method for antifungal disk diffusion susceptibility testing of yeasts: approved guideline. M44-A. Wayne, PA: NCCLS, 2004.
12. Hazen KC, Baron EJ, Colombo AL, Girmenia C, Sanchez-Sousa A, del Palacio A, et al. Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-yr global evaluation using disk diffusion. J Clin Microbiol 2003;41:5623-32. (Pubitemid 37543257)
13. Kang BK, Lee HJ, Suh JT. The Trends of the species and antimicrobial susceptibility of bacteria and fungi isolated from blood cultures (1986-1996). Korean J Clin Pathol 1998;18:57-64.
14. Uh Y, Jang IH, Yoon KJ, Kim HY. Isolation trend and antifungal susceptibility of Candida species isolated from blood cultures. Korean J Infect Dis 2001;33:186-93.
15. Kim YA, Cho DH, Lee K, Chong Y, Kwon HK. Yeasts isolated from oral cavity of the healthy adults. Korean J Clin Pathol 2000; 20:30-5.
16. Lee SH, Kim SW, Bang YJ. A study on the distribution of oral candidal isolates in diabetics. Korean J Med Mycol 2002;7:139-48. (Pubitemid 35477155)
17. Choi JH, Suh MK, Ha GY. Isolation and identification of Candida species in superficial cutaneous candidiasis. Korean J Dermatol 2002;40:1188-94. (Pubitemid 35477185)
18. Pfaller MA, Hazen KC, Messer SA, Boyken L, Tendolkar S, Hollis RJ, et al. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program. J Clin Microbiol 2004;42:3607-12. (Pubitemid 39045688)
19. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, et al. Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Microbiol Infect Dis 2009;65:27-34.